Bienvenue dans – Welkom bij:
Bienvenidos en – Welcome to:
SFB-Pharma
If you want to reach me please send a message to:
Christine Laroche [email protected]
DRUGS.COM – NEW APPROVALS BELOW
- FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
- FDA Approves Jaypirca (pirtobrutinib) for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
- FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes
- Brukinsa (zanubrutinib) Approved in the U.S. for Chronic Lymphocytic Leukemia
- Seagen Announces FDA Accelerated Approval of Tukysa (tucatinib) in Combination with Trastuzumab for People with Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer